Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE.

Chronic traumatic encephalopathy Neurodegenerative disease Repetitive head impacts Traumatic brain injury

Journal

Acta neuropathologica
ISSN: 1432-0533
Titre abrégé: Acta Neuropathol
Pays: Germany
ID NLM: 0412041

Informations de publication

Date de publication:
26 Feb 2024
Historique:
received: 31 07 2023
accepted: 11 01 2024
revised: 10 01 2024
medline: 26 2 2024
pubmed: 26 2 2024
entrez: 26 2 2024
Statut: epublish

Résumé

Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease caused by repetitive head impacts (RHI) and pathologically defined as neuronal phosphorylated tau aggregates around small blood vessels and concentrated at sulcal depths. Cross-sectional studies suggest that tau inclusions follow a stereotyped pattern that begins in the neocortex in low stage disease, followed by involvement of the medial temporal lobe and subcortical regions with significant neocortical burden in high stage CTE. Here, we define a subset of brain donors with high stage CTE and with a low overall cortical burden of tau inclusions (mean semiquantitative value ≤1) and classify them as cortical-sparing CTE (CSCTE). Of 620 brain donors with pathologically diagnosed CTE, 66 (11%) met criteria for CSCTE. Compared to typical high stage CTE, those with CSCTE had a similar age at death and years of contact sports participation and were less likely to carry apolipoprotein ε4 (p < 0.05). CSCTE had less overall tau pathology severity, but a proportional increase of disease burden in medial temporal lobe and brainstem regions compared to the neocortex (p's < 0.001). CSCTE also had lower prevalence of comorbid neurodegenerative disease. Clinically, CSCTE participants were less likely to have dementia (p =  0.023) and had less severe cognitive difficulties (as reported by informants using the Functional Activities Questionnaire (FAQ); p < 0.001, meta-cognitional index T score; p = 0.002 and Cognitive Difficulties Scale (CDS); p < 0.001,) but had an earlier onset age of behavioral (p = 0.006) and Parkinsonian motor (p = 0.013) symptoms when compared to typical high stage CTE. Other comorbid tauopathies likely contributed in part to these differences: when cases with concurrent Alzheimer dementia or frontal temporal lobar degeneration with tau pathology were excluded, differences were largely retained, but only remained significant for FAQ (p = 0.042), meta-cognition index T score (p = 0.014) and age of Parkinsonian motor symptom onset (p = 0.046). Overall, CSCTE appears to be a distinct subtype of high stage CTE with relatively greater involvement of subcortical and brainstem regions and less severe cognitive symptoms.

Identifiants

pubmed: 38407651
doi: 10.1007/s00401-024-02690-5
pii: 10.1007/s00401-024-02690-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

45

Subventions

Organisme : Alzheimer's Association
ID : NIRG-305779
Pays : United States
Organisme : Alzheimer's Association
ID : NIRG-362697
Pays : United States
Organisme : NINDS NIH HHS
ID : U54NS115266
Pays : United States
Organisme : NINDS NIH HHS
ID : U01NS086659
Pays : United States
Organisme : NINDS NIH HHS
ID : K23NS102399
Pays : United States
Organisme : NINDS NIH HHS
ID : RF1NS122854
Pays : United States

Informations de copyright

© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

Adams JW, Alvarez VE, Mez J, Huber BR, Tripodis Y, Xia W et al (2018) Lewy body pathology and chronic traumatic encephalopathy associated with contact sports. J Neuropathol Exp Neurol 77:757–768. https://doi.org/10.1093/jnen/nly065
doi: 10.1093/jnen/nly065 pubmed: 30053297 pmcid: 6097837
Alosco ML, Cherry JD, Huber BR, Tripodis Y, Baucom Z et al (2020) Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme. Acta Neuropathol (Berl) 140:495–512. https://doi.org/10.1007/s00401-020-02197-9
doi: 10.1007/s00401-020-02197-9 pubmed: 32778942
Alosco ML, Ly M, Mosaheb S, Saltiel N, Uretsky M, Tripodis Y et al (2023) Decreased myelin proteins in brain donors exposed to football-related repetitive head impacts. Brain Commun 5:fcad019. https://doi.org/10.1093/braincomms/fcad019
Alosco ML, Mez J, Tripodis Y, Kiernan PT, Abdolmohammadi B, Murphy L et al (2018) Age of first exposure to tackle football and chronic traumatic encephalopathy. Ann Neurol 83:886–901. https://doi.org/10.1002/ana.25245
doi: 10.1002/ana.25245 pubmed: 29710395 pmcid: 6367933
Alosco ML, Mian AZ, Buch K, Farris CW, Uretsky M, Tripodis Y et al (2021) Structural MRI profiles and tau correlates of atrophy in autopsy-confirmed CTE. Alzheimers Res Ther 13:193. https://doi.org/10.1186/s13195-021-00928-y
doi: 10.1186/s13195-021-00928-y pubmed: 34876229 pmcid: 8653514
Alosco ML, Stein TD, Tripodis Y, Chua AS, Kowall NW, Huber BR et al (2019) Association of White Matter Rarefaction, Arteriolosclerosis, and Tau With Dementia in Chronic Traumatic Encephalopathy. JAMA Neurol 76:1298–1308. https://doi.org/10.1001/jamaneurol.2019.2244
doi: 10.1001/jamaneurol.2019.2244 pubmed: 31380975 pmcid: 6686769
Atherton K, Han X, Chung J, Cherry JD, Baucom Z, Saltiel N et al (2022) Association of APOE genotypes and chronic traumatic encephalopathy. JAMA Neurol 79:787. https://doi.org/10.1001/jamaneurol.2022.1634
doi: 10.1001/jamaneurol.2022.1634 pubmed: 35759276 pmcid: 9237800
Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G et al (2021) Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol (Berl) 141:159–172. https://doi.org/10.1007/s00401-020-02255-2
doi: 10.1007/s00401-020-02255-2 pubmed: 33399945
Bieniek KF, Cairns NJ, Crary JF, Dickson DW, Folkerth RD, Keene CD et al (2021) The Second NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. J Neuropathol Exp Neurol. Publish Ahead of Print. https://doi.org/10.1093/jnen/nlab001
Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979) Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1:131–139. https://doi.org/10.1016/0165-1781(79)90053-2
doi: 10.1016/0165-1781(79)90053-2 pubmed: 95232
Butler MLMD, Dixon E, Stein TD, Alvarez VE, Huber B, Buckland ME et al (2022) Tau pathology in chronic traumatic encephalopathy is primarily neuronal. J Neuropathol Exp Neurol 81:773–780. https://doi.org/10.1093/jnen/nlac065
doi: 10.1093/jnen/nlac065 pubmed: 35903039 pmcid: 9487650
Cherry JD, Mez J, Crary JF, Tripodis Y, Alvarez VE, Mahar I et al (2018) Variation in TMEM106B in chronic traumatic encephalopathy. Acta Neuropathol Commun 6:115. https://doi.org/10.1186/s40478-018-0619-9
doi: 10.1186/s40478-018-0619-9 pubmed: 30390709 pmcid: 6215686
Crook T (1983) Assessment in geriatric psychopharmacology. Mark Powley Associates, New Canaan, CT
Farrell K, Iida MA, Cherry JD, Casella A, Stein TD, Bieniek KF et al (2022) Differential vulnerability of hippocampal subfields in primary age-related tauopathy and chronic traumatic encephalopathy. J Neuropathol Exp Neurol 81:781–789. https://doi.org/10.1093/jnen/nlac066
doi: 10.1093/jnen/nlac066 pubmed: 36004533 pmcid: 9487677
Gioia GA, Isquith PK, Guy SC, Kenworthy L (2000) TEST REVIEW behavior rating inventory of executive function. Child Neuropsychol 6:235–238. https://doi.org/10.1076/chin.6.3.235.3152
doi: 10.1076/chin.6.3.235.3152
Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 8:1–13. https://doi.org/10.1016/j.jalz.2011.10.007
doi: 10.1016/j.jalz.2011.10.007 pubmed: 22265587 pmcid: 3266529
Iida MA, Farrell K, Walker JM, Richardson TE, Marx GA, Bryce CH et al (2021) Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study. Acta Neuropathol Commun 9:134. https://doi.org/10.1186/s40478-021-01233-3
doi: 10.1186/s40478-021-01233-3 pubmed: 34353357 pmcid: 8340493
Janocko NJ, Brodersen KA, Soto-Ortolaza AI, Ross OA, Liesinger AM, Duara R et al (2012) Neuropathologically defined subtypes of Alzheimer’s disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol (Berl) 124:681–692. https://doi.org/10.1007/s00401-012-1044-y
doi: 10.1007/s00401-012-1044-y pubmed: 22968369
Katz DI, Bernick C, Dodick DW, Mez J, Mariani ML, Adler CH et al (2021) National institute of neurological disorders and stroke consensus diagnostic criteria for traumatic encephalopathy syndrome. Neurology 96:848–863. https://doi.org/10.1212/WNL.0000000000011850
doi: 10.1212/WNL.0000000000011850 pubmed: 33722990 pmcid: 8166432
Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H et al (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol (Berl) 131:87–102. https://doi.org/10.1007/s00401-015-1509-x
doi: 10.1007/s00401-015-1509-x pubmed: 26659578
Liu C-C, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106–118. https://doi.org/10.1038/nrneurol.2012.263
doi: 10.1038/nrneurol.2012.263 pubmed: 23296339 pmcid: 3726719
Mackenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol (Berl) 119:1–4. https://doi.org/10.1007/s00401-009-0612-2
doi: 10.1007/s00401-009-0612-2 pubmed: 19924424
McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE et al (2009) Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 68:709–735. https://doi.org/10.1097/NEN.0b013e3181a9d503
doi: 10.1097/NEN.0b013e3181a9d503 pubmed: 19535999
McKee AC, Stein TD, Kiernan PT, Alvarez VE (2015) The neuropathology of chronic traumatic encephalopathy. Brain Pathol Zurich Switz 25:350–364. https://doi.org/10.1111/bpa.12248
doi: 10.1111/bpa.12248
McKee AC, Stein TD, Nowinski CJ, Stern RA, Daneshvar DH, Alvarez VE et al (2013) The spectrum of disease in chronic traumatic encephalopathy. Brain 136:43–64. https://doi.org/10.1093/brain/aws307
doi: 10.1093/brain/aws307 pubmed: 23208308
Mendez MF (1995) The neuropsychiatric aspects of boxing. Int J Psychiatry Med 25:249–262. https://doi.org/10.2190/CUMK-THT1-X98M-WB4C
doi: 10.2190/CUMK-THT1-X98M-WB4C pubmed: 8567192
Mez J, Daneshvar DH, Abdolmohammadi B, Chua AS, Alosco ML, Kiernan PT et al (2020) Duration of American football play and chronic traumatic encephalopathy. Ann Neurol 87:116–131. https://doi.org/10.1002/ana.25611
doi: 10.1002/ana.25611 pubmed: 31589352
Mez J, Daneshvar DH, Kiernan PT, Abdolmohammadi B, Alvarez VE, Huber BR et al (2017) Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA 318:360. https://doi.org/10.1001/jama.2017.8334
doi: 10.1001/jama.2017.8334 pubmed: 28742910 pmcid: 5807097
Mez J, Solomon TM, Daneshvar DH, Murphy L, Kiernan PT, Montenigro PH et al (2015) Assessing clinicopathological correlation in chronic traumatic encephalopathy: rationale and methods for the UNITE study. Alzheimers Res Ther 7:62. https://doi.org/10.1186/s13195-015-0148-8
doi: 10.1186/s13195-015-0148-8 pubmed: 26455775 pmcid: 4601147
Alosco ML, White M, Bell C, Faheem F, Tripodis Y, Yhang E et al (2024) Cognitive, functional, and neuropsychiatric correlates of regional tau pathology in autopsy-confirmed chronic traumatic encephalopathy. Mol Neurodegener 19(1):10. https://doi.org/10.1186/s13024-023-00697-2
doi: 10.1186/s13024-023-00697-2 pubmed: 38317248 pmcid: 10845638
Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol (Berl) 123:1–11. https://doi.org/10.1007/s00401-011-0910-3
doi: 10.1007/s00401-011-0910-3 pubmed: 22101365
Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K et al (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain J Neurol 142:1503–1527. https://doi.org/10.1093/brain/awz099
doi: 10.1093/brain/awz099
Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET (1999) Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 58:1147–1155. https://doi.org/10.1097/00005072-199911000-00004
doi: 10.1097/00005072-199911000-00004 pubmed: 10560657
Nicks R, Clement NF, Alvarez VE, Tripodis Y, Baucom ZH, Huber BR et al (2023) Repetitive head impacts and chronic traumatic encephalopathy are associated with TDP-43 inclusions and hippocampal sclerosis. Acta Neuropathol (Berl) 145:395–408. https://doi.org/10.1007/s00401-023-02539-3
doi: 10.1007/s00401-023-02539-3 pubmed: 36681782
Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the barratt impulsiveness scale. J Clin Psychol 51:768–774. https://doi.org/10.1002/1097-4679(199511)51:6%3c768::AID-JCLP2270510607%3e3.0.CO;2-1
doi: 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1 pubmed: 8778124
Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S (1982) Measurement of functional activities in older adults in the community. J Gerontol 37:323–329. https://doi.org/10.1093/geronj/37.3.323
doi: 10.1093/geronj/37.3.323 pubmed: 7069156
Roemer SF, Grinberg LT, Crary JF, Seeley WW, McKee AC, Kovacs GG et al (2022) Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol (Berl) 144:603–614. https://doi.org/10.1007/s00401-022-02479-4
doi: 10.1007/s00401-022-02479-4 pubmed: 35947184
Standring OJ, Friedberg J, Tripodis Y, Chua AS, Cherry JD, Alvarez VE et al (2019) Contact sport participation and chronic traumatic encephalopathy are associated with altered severity and distribution of cerebral amyloid angiopathy. Acta Neuropathol (Berl) 138:401–413. https://doi.org/10.1007/s00401-019-02031-x
doi: 10.1007/s00401-019-02031-x pubmed: 31183671
Stathas S, Alvarez VE, Xia W, Nicks R, Meng G, Daley S et al (2022) Tau phosphorylation sites serine202 and serine396 are differently altered in chronic traumatic encephalopathy and Alzheimer’s disease. Alzheimers Dement J Alzheimers Assoc 18:1511–1522. https://doi.org/10.1002/alz.12502
doi: 10.1002/alz.12502
Stein TD, Montenigro PH, Alvarez VE, Xia W, Crary JF, Tripodis Y et al (2015) Beta-amyloid deposition in chronic traumatic encephalopathy. Acta Neuropathol (Berl) 130:21–34. https://doi.org/10.1007/s00401-015-1435-y
doi: 10.1007/s00401-015-1435-y pubmed: 25943889
the TBI/CTE group, McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Dirk Keene C et al (2016) The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol (Berl) 131:75–86. https://doi.org/10.1007/s00401-015-1515-z
Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S et al (2016) Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology. Acta Neuropathol (Berl) 131:393–409. https://doi.org/10.1007/s00401-015-1526-9
doi: 10.1007/s00401-015-1526-9 pubmed: 26721587
Vonsattel JPG, Del Amaya MP, Keller CE (2008) Twenty-first century brain banking. Processing brains for research: the Columbia University methods. Acta Neuropathol (Berl) 115:509–532. https://doi.org/10.1007/s00401-007-0311-9
doi: 10.1007/s00401-007-0311-9 pubmed: 17985145
Walker JM, Fudym Y, Farrell K, Iida MA, Bieniek KF, Seshadri S et al (2021) Asymmetry of hippocampal tau pathology in primary age-related tauopathy and Alzheimer disease. J Neuropathol Exp Neurol 80:436–445. https://doi.org/10.1093/jnen/nlab032
doi: 10.1093/jnen/nlab032 pubmed: 33860327 pmcid: 8054137

Auteurs

Abigail Alexander (A)

Division of Neuropathology, Lifespan Academic Medical Center, The Warren Alpert Medical School, Brown University, Providence, RI, USA.

Victor E Alvarez (VE)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Department of Neurology, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
VA Bedford Healthcare System, Bedford, MA, USA.
VA Boston Healthcare System, U.S. Department of Veteran Affairs, Jamaica Plain, MA, USA.

Bertrand R Huber (BR)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
VA Boston Healthcare System, U.S. Department of Veteran Affairs, Jamaica Plain, MA, USA.

Michael L Alosco (ML)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Department of Neurology, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.

Jesse Mez (J)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Department of Neurology, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.

Yorghos Tripodis (Y)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Raymond Nicks (R)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
VA Bedford Healthcare System, Bedford, MA, USA.
VA Boston Healthcare System, U.S. Department of Veteran Affairs, Jamaica Plain, MA, USA.

Douglas I Katz (DI)

Department of Neurology, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Braintree Rehabilitation Hospital, Braintree, MA, USA.

Brigid Dwyer (B)

Department of Neurology, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Braintree Rehabilitation Hospital, Braintree, MA, USA.

Daniel H Daneshvar (DH)

Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.

Brett Martin (B)

Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA, USA.

Joseph Palmisano (J)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA, USA.

Lee E Goldstein (LE)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Department of Radiology, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Departments of Pathology and Laboratory Medicine, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Department of Psychiatry, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Departments of Biomedical, Electrical & Computer Engineering, Boston University College of Engineering, Boston, MA, USA.

John F Crary (JF)

Department of Pathology, Nash Family Department of Neuroscience, Department of Artificial Intelligence and Human Health, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Christopher Nowinski (C)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Concussion Legacy Foundation, Boston, MA, USA.

Robert C Cantu (RC)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Concussion Legacy Foundation, Boston, MA, USA.
Department of Neurosurgery, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Department of Neurosurgery, Emerson Hospital, Concord, MA, USA.

Neil W Kowall (NW)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

Robert A Stern (RA)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Department of Neurosurgery, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.

Ivana Delalle (I)

Division of Neuropathology, Lifespan Academic Medical Center, The Warren Alpert Medical School, Brown University, Providence, RI, USA.

Ann C McKee (AC)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Department of Neurology, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA.
VA Boston Healthcare System, U.S. Department of Veteran Affairs, Jamaica Plain, MA, USA.

Thor D Stein (TD)

Boston University Alzheimer's Disease Research Center and CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. tdstein@bu.edu.
VA Bedford Healthcare System, Bedford, MA, USA. tdstein@bu.edu.
VA Boston Healthcare System, U.S. Department of Veteran Affairs, Jamaica Plain, MA, USA. tdstein@bu.edu.
Departments of Pathology and Laboratory Medicine, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA, USA. tdstein@bu.edu.
, 150 S. Huntington Avenue, Boston, MA, 02130, USA. tdstein@bu.edu.

Classifications MeSH